Key result
Monitoring natriuretic peptides during cardiac rehabilitation may cost-effectively guide interventions in heart failure patients.
Why the study?
Although cardiac rehabilitation improves outcomes in heart failure, the use of cardiac biomarkers like natriuretic peptides to monitor rehabilitation programs remains poorly adopted and characterized.
Does the measurement of cardiac biomarkers (natriuretic peptides) improve the monitoring and modulation of cardiac rehabilitation programs in patients with heart failure?
Does the measurement of cardiac biomarkers (natriuretic peptides) improve the monitoring and modulation of cardiac rehabilitation programs in patients with heart failure?
This review highlights the potential clinical utility of natriuretic peptides as a cost-effective tool for monitoring and tailoring cardiac rehabilitation in heart failure patients.
Heart failure (HF) is characterized by poor exercise tolerance and reduced ability to perform routine daily activities. Cardiac rehabilitation (CR), which includes exercise training, has shown a role in improving cardiac remodeling, functional capacity and HF outcomes as a consequence of its beneficial effects on neurohormonal dysfunction, endothelial function, vascular tone and peripheral oxygen extraction. Although a multiparametric evaluation, including physical examination, blood sampling, echocardiographic and cardiopulmonary exercise testing parameters, is routinely performed during CR programs, the use of cardiac biomarkers, in particular natriuretic peptides (NPs), is still poorly adopted and characterized. In this article we analyze the potential role of biomarkers in monitoring the success of rehabilitation programs and the potential implications of their use in clinical practice. Indeed, NPs measurements might represent an important tool to modulate the rehabilitative interventions with a favorable cost-effectiveness profile.
No takes yet. Share an insight, caveat, or question.
Gallo et al. (2025) conducted a review in Heart failure. Biomarker monitoring (natriuretic peptides) during cardiac rehabilitation was evaluated. Monitoring cardiac biomarkers, particularly natriuretic peptides, during cardiac rehabilitation in heart failure patients may provide a cost-effective tool to modulate rehabilitative interventions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: